| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harvard Apparatus Regenerative Technology, Inc. (HRGN) has 8 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. HRGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 280.6K | $420.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2015 | Green David | Chief Executive Officer | Buy | 50,000 | $1.75 | $87,500.00 | +14.8% | |
| Feb 13, 2015 | McNaughton Thomas | Chief Financial Officer | Buy | 14,000 | $2.67 | $37,380.00 | +26.5% |